ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer

Ramesh, Saravanan; Selvakumar, Preethi; Ameer, Mohamed Yazeer; Lian, Sen; Abdullah Alzarooni, Abdulqadir Ismail M.; Ojha, Shreesh; Mishra, Anshuman; Tiwari, Ashutosh; Kaushik, Ajeet; Jung, Young Do; Chouaib, Salem; Lakshmanan, Vinoth-Kumar*南方医科大学
Frontiers in Oncology2023-3-9DOI: 10.3389/fonc.2023.1059441
2被引6阅读
引用收藏
分享

摘要

The development of new therapeutic strategies is on the increase for prostate cancer stem cells, owing to current standardized therapies for prostate cancer, including chemotherapy, androgen deprivation therapy (ADT), radiotherapy, and surgery, often failing because of tumor relapse ability. Ultimately, tumor relapse develops into advanced castration-resistant prostate cancer (CRPC), which becomes an irreversible and systemic disease. Hence, early identification of the intracellular components and molecular networks that promote prostate cancer is crucial for disease management and therapeutic intervention. One of the potential therapeutic methods for aggressive prostate cancer is to target prostate cancer stem cells (PCSCs), which appear to be a primary focal point of cancer metastasis and recurrence and are resistant to standardized therapies. PCSCs have also been documented to play a major role in regulating tumorigenesis, sphere formation, and the metastasis ability of prostate cancer with their stemness features. Therefore, the current review highlights the origin and identification of PCSCs and their role in anti-androgen resistance, as well as stemness-related signaling pathways. In addition, the review focuses on the current advanced therapeutic strategies for targeting PCSCs that are helping to prevent prostate cancer initiation and progression, such as microRNAs (miRNAs), nanotechnology, chemotherapy, immunotherapy, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene-editing system, and photothermal ablation (PTA) therapy.

学科与关键词

关键词
prostate cancercancer stem cellsimmunotherapychemotherapyCRISPRnanotechnologyphotothermal ablation therapy
相关
加载中…
  • MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
    Gan, Junqing; Liu, Shan; Zhang, Yu; He, Liangzi; Bai, Lu; Liao, Ran; Zhao, Juan; Guo, Madi; Jiang, Wei; Li, Jiade; Li, Qi; Mu, Guannan; Wu, Yangjiazi; Wang, Xinling; Zhang, Xingli; Zhou, Dan; Lv, Huimin; Wang, Zhengfeng; Zhang, Yanqiao; Qian, Cheng; Feng, MeiYan; Chen, Hui; Meng, Qingwei; Huang, Xiaoyi*Experimental and Molecular Medicine, 2022, 54(8): 1290-1305.被引 16
  • Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance
    Jian, Jingang; Wang, Xin'an; Zhang, Jun; Zhou, Chenchao; Hou, Xiaorui; Huang, Yuhua; Hou, Jianquan*; Lin, Yuxin*; Wei, Xuedong*Frontiers in Endocrinology, 2024, 15: 1360430.
  • Current therapy and drug resistance in metastatic castration-resistant prostate cancer
    Cai, Maoping; Song, Xian-Lu; Li, Xin-An; Chen, Mingkun; Guo, Jiading; Yang, Dong Hua*; Chen, Zhanghui*; Zhao, Shan-Chao*DRUG RESISTANCE UPDATES, 2023, 68: 100962.被引 19
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-03-09
卷期
第 13 卷
页码
1059441
DOI
10.3389/fonc.2023.1059441
成果收录
SCIE

作者

  • R

    Ramesh, Saravanan (第一作者)

  • S

    Selvakumar, Preethi

查看全部 12 位作者收起作者
  • A

    Ameer, Mohamed Yazeer

  • L

    Lian, Sen

    southern med univ

  • A

    Abdullah Alzarooni, Abdulqadir Ismail M.

  • O

    Ojha, Shreesh

    ain

  • M

    Mishra, Anshuman

  • T

    Tiwari, Ashutosh

  • K

    Kaushik, Ajeet

    polytech univ

  • J

    Jung, Young Do

  • C

    Chouaib, Salem

  • L

    Lakshmanan, Vinoth-Kumar (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417